Cite

HARVARD Citation

    Abgral, R. et al. (2022). Impressive Rapid Complete Response on FDG PET/CT to BRAF Inhibitors in a Metastatic Melanoma With Massive Tumor Burden. Clinical nuclear medicine. p. . [Online]. 
  
Back to record